Seracam® Demonstrates Feasibility for Sentinel Lymph Node Imaging at IPET 2024
- Serac Life Sciences
- October 11, 2024
- Edited 4 months ago
Serac Imaging Systems announces that its clinical partner, the University of Malaya Medical Centre, has today presented initial findings and images acquired using Seracam® for image guided surgery in a sentinel lymph node biopsy procedure at the International Conference on Hybrid Imaging (IPET 2024) organised by the International Atomic Energy Agency (IAEA). Based on this first user case, the investigators have determined that Seracam® demonstrates clinical feasibility for sentinel lymph node imaging in breast cancer management.